Tuesday 18 May 2010

Gadobenic Acid




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V08CA,V08CA08

CAS registry number (Chemical Abstracts Service)

0113662-23-0

Chemical Formula

C22-H28-Gd-N3-O11

Molecular Weight

667

Therapeutic Category

Contrast medium

Chemical Names

Dihydrogen ((+-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-- triazatridecan-13-oato(5-))gadolinate(2-), compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)

Dihydrogen[(+/-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-)]gadolinate(2-) (WHO)

Dihydrogen[(+/-)-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-)]gadolinat(2-) (IUPAC)

Gadolinate(2-), (4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triaz- atridecan-13-oato(5-)-N5,N8,N11,O4,O5,O8,O11,O13)-, dihydrogen

Foreign Names

  • Acidum gadobenicum (Latin)
  • Gadobensäure (German)
  • Acide gadobenique (French)
  • Acido gadobenico (Spanish)

Generic Names

  • Gadobenic Acid (OS: BAN)
  • B 19036 (IS: Bracco)
  • Gd-BOPTA (IS: Bracco)
  • Gadobenate Dimeglumine (OS: USAN)
  • B 19036/7 (IS: Bracco)
  • Gd-BOPTA/Dimeg (IS)

Brand Names

  • MultiHance
    Regional Health, New Zealand; Altana, Belgium; Altana, Luxembourg; Auremiana, Slovenia; Bracco, Austria; Bracco, Czech Republic; Bracco, France; Bracco, Hungary; Bracco, Israel; Bracco, Italy; Bracco, Luxembourg; Bracco, Norway; Bracco, Poland; Bracco, Romania; Bracco, United States; Bracco Imaging, Germany; Bracco SpA, Denmark; Bracco Suisse, Switzerland; Initios, Sweden; png Gerolymatos, Greece; Rovi, Spain

International Drug Name Search

Glossary

BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment